The Negatives: What the Trials Showed Across programs like STEP, SURMOUNT, and SELECT, side effects were largely gastrointestinal: Nausea, vomiting, constipation, diarrhea
Abstract Background Oral semaglutide is a novel tablet containing the human glucagon-like peptide-1 (GLP1) analogue semaglutide, co-formulated with the absorption enhancer sodium N -(8-[2-hydroxybenzoyl] amino) caprylate (SNAC)
Journal Of The American College Of Cardiology 2026, 87: 683-684
Nonsteroidal MRA Several nonsteroidal antagonists of the mineralocorticoid receptor (MRA) are in clinical development with a clear focus on the treatment of diabetic kidney diseases
Reported Research Benefits Preclinical studies target muscle recovery, tendon and ligament repair, wound healing, anti-aging skin therapies, neuroprotection, angiogenesis promotion, and immunomodulation